Literature DB >> 25546759

Benefits, efficacy, cost-effectiveness and infectious complications in transplant patients desensitized with intravenous immunoglobulin and anti-CD20 therapy.

A A Vo1, S C Jordan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25546759      PMCID： PMC4285488          DOI： 10.1111/cei.12508

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  31 in total

1.  Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study.

Authors:  Alexandre Loupy; Caroline Suberbielle-Boissel; Julien Zuber; Dany Anglicheau; Marc-Olivier Timsit; Frank Martinez; Eric Thervet; Patrick Bruneval; Dominique Charron; Gary S Hill; Dominique Nochy; Christophe Legendre
Journal:  Transplantation       Date:  2010-06-15       Impact factor: 4.939

2.  Lack of effect in desensitization with intravenous immunoglobulin and rituximab in highly sensitized patients.

Authors:  Kwaku Marfo; Ming Ling; Yi Bao; Brant Calder; Bin Ye; Nicole Hayde; Stuart Greenstein; Javier Chapochnick-Friedman; Daniel Glicklich; Graciela de Boccardo; Milan Kinkhabwala; Enver Akalin
Journal:  Transplantation       Date:  2012-08-27       Impact factor: 4.939

Review 3.  Effector and regulatory B cells: modulators of CD4+ T cell immunity.

Authors:  Frances E Lund; Troy D Randall
Journal:  Nat Rev Immunol       Date:  2010-03-12       Impact factor: 53.106

4.  Summary of FDA antibody-mediated rejection workshop.

Authors:  P Archdeacon; M Chan; C Neuland; E Velidedeoglu; J Meyer; L Tracy; M Cavaille-Coll; S Bala; A Hernandez; R Albrecht
Journal:  Am J Transplant       Date:  2011-05       Impact factor: 8.086

5.  Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

Authors:  Stanley C Jordan; Dolly Tyan; Don Stablein; Matthew McIntosh; Steve Rose; Ashley Vo; Mieko Toyoda; Connie Davis; Ron Shapiro; Deborah Adey; Dawn Milliner; Ralph Graff; Robert Steiner; Gaetano Ciancio; Shobah Sahney; Jimmy Light
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

6.  Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.

Authors:  F K Port; R A Wolfe; E A Mauger; D P Berling; K Jiang
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

7.  Reduced T-dependent humoral immunity in CD20-deficient mice.

Authors:  Deyaa El Deen Morsy; Ratna Sanyal; Anne K Zaiss; Rucha Deo; Dan A Muruve; Julie P Deans
Journal:  J Immunol       Date:  2013-08-21       Impact factor: 5.422

Review 8.  The spectrum of antibody-mediated renal allograft injury: implications for treatment.

Authors:  J Gloor; F Cosio; D J Lager; M D Stegall
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

9.  Rituximab and intravenous immune globulin for desensitization during renal transplantation.

Authors:  Ashley A Vo; Marina Lukovsky; Mieko Toyoda; Jennifer Wang; Nancy L Reinsmoen; Chih-Hung Lai; Alice Peng; Rafael Villicana; Stanley C Jordan
Journal:  N Engl J Med       Date:  2008-07-17       Impact factor: 91.245

10.  The quality of life of patients with end-stage renal disease.

Authors:  R W Evans; D L Manninen; L P Garrison; L G Hart; C R Blagg; R A Gutman; A R Hull; E G Lowrie
Journal:  N Engl J Med       Date:  1985-02-28       Impact factor: 91.245
View more
  2 in total

1.  Desensitisation strategies in high-risk children before kidney transplantation.

Authors:  Ankit Sharma; Anne M Durkan
Journal:  Pediatr Nephrol       Date:  2018-01-13       Impact factor: 3.714

2.  Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.

Authors:  Tomas Lorant; Mats Bengtsson; Torsten Eich; Britt-Marie Eriksson; Lena Winstedt; Sofia Järnum; Yvonne Stenberg; Anna-Karin Robertson; Kristina Mosén; Lars Björck; Lars Bäckman; Erik Larsson; Kathryn Wood; Gunnar Tufveson; Christian Kjellman
Journal:  Am J Transplant       Date:  2018-04-17       Impact factor: 8.086
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.